City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
City of Hope Investigational Drug Services (IDS), Duarte
UC San Diego Medical Center - Encinitas, Encinitas
dan 13 lagi

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07227415

TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma

USC Norris Comprehensive Cancer Center, Los Angeles

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT04969315

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

City of Hope Medical Center, Duarte
University of California San Diego Medical Center, Moores Cancer Center, La Jolla

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07195916

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

University of California, San Diego, La Jolla
Hoag Memorial Hospital Presbyterian, Newport Beach
Redwood City, Redwood City

Mengambil pesertaKajian pemerhatian

Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT05059444

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Sutter Auburn Faith Hospital, Auburn
Tower Cancer Research Foundation, Beverly Hills
City of Hope Comprehensive Cancer Center, Duarte
dan 23 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06661720

Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

City of Hope Medical Center, Duarte
City of Hope at Irvine Lennar, Irvine

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 31 Ogo 2026 · NCT05830058

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

University of Southern California, Los Angeles
Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
Cedars-Sanai Medical Center, Los Angeles
dan 1 lagi

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT06582017

Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT06432036

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

City of Hope National Medical Center, Duarte
Chao Family Comprehensive Cancer Center, Orange

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT05361720

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Community Cancer Institute, Clovis
USC/Norris Comprehensive Cancer Center, Los Angeles
Hoag Memorial Hospital Presbyterian, Newport Beach

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT04895709

A Study of MGC026 in Participants With Advanced Solid Tumors

The Angeles Clinic and Research Institute, Los Angeles

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT06242470

Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer

City of Hope Medical Center, Duarte

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT07226544

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

Providence Medical Foundation ( Site 0141), Fullerton
USC Norris Comprehensive Cancer Center ( Site 0126), Los Angeles
Cedars-Sinai Medical Center ( Site 0112), Los Angeles

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT07227402

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Xencor Investigative Site, Duarte
Xencor Investigative Site, Sacramento

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT05433142

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

City of Hope, Duarte
Los Angeles Cancer Network, Glendale
California Research Institute, Los Angeles
dan 3 lagi

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jul 2026 · NCT04198766

Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases

University of California, San Francisco, San Francisco

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT07043608

Imaging of Solid Tumors Using 18F-TRX

University of California, San Francisco, San Francisco

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jul 2026 · NCT06942104

Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer

City of Hope Medical Center, Duarte
City of Hope Medical Center, Irvine

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 16 Jul 2026 · NCT07128680

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

John Wayne Cancer Institute (JWCI), Santa Monica

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 9 Jul 2026 · NCT03972657

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

University of California, Davis, Sacramento

Mengambil peserta

Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jun 2026 · NCT06101290

An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 15 Jun 2026 · NCT06447103

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

Start Lacn, Los Angeles

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 10 Jun 2026 · NCT07517198

Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery

City of Hope Medical Center, Duarte
City of Hope at Irvine Lennar, Irvine

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 9 Jun 2026 · NCT07037004

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

University of Southern California, Los Angeles
Cedars-Sinai Medical Center, Los Angeles
UCLA Department of Medicine, Los Angeles

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 8 Jun 2026 · NCT06026410

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

City of Hope, Irvine

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 20 Mei 2026 · NCT06053658

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.